Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference

Lexicon Pharmaceuticals (Nasdaq:LXRX) announced that management will take part in a fireside chat at the 4th Annual H.C.

Rhea-AI Summary

Lexicon Pharmaceuticals (Nasdaq:LXRX) announced that management will take part in a fireside chat at the 4th Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq World Headquarters in New York City on May 19, 2026. A live webcast and replay will be available on the company’s investor relations Events page.

Argus May 12 session

+4.33% close to close Open Argus

Details

News Market Reaction – LXRX

In the May 12 session, LXRX gained 4.33%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Lexicon’s participation in an investor-focused fireside chat at the H.C...

Analysis

This announcement highlights Lexicon’s participation in an investor-focused fireside chat at the H.C. Wainwright BioConnect conference on May 19, 2026, adding to a steady cadence of visibility events alongside recent earnings, financing and scientific data presentations. Historical context shows positive share reactions to prior updates and improved Q1 2026 fundamentals. Investors tracking the story may watch subsequent clinical milestones, future financial reports, and additional investor conferences for incremental information.

Key Figures

Conference date: May 19, 2026 Conference edition: 4th Annual

Conference date

May 19, 2026

Date of fireside chat at H.C. Wainwright BioConnect

Conference edition

4th Annual

H.C. Wainwright BioConnect Investor Conference

Historical Context

5 past events · Latest: May 07

5 events

1. May 07

   Earnings & pipeline

   24h Move

   +5.0%

   Q1 2026 results with higher revenue and multiple clinical program updates.

2. May 04

   Debt financing

   24h Move

   +3.1%

   New $100M Hercules loan facility with initial $55M tranche to refinance debt.

3. Apr 30

   Earnings date set

   24h Move

   +3.9%

   Announcement of Q1 2026 results date and conference call logistics.

4. Apr 17

   Neurology data

   24h Move

   +1.6%

   AAN presentations featuring Phase 2b and preclinical data for pilavapadin and spasticity.

5. Mar 24

   Cardiology data

   24h Move

   +4.9%

   ACC presentations on sotagliflozin including SCORED and SOTA-P-CARDIA analyses.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

THE WOODLANDS, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 4th Annual H.C. Wainwright BioConnect Investor Conference, taking place at the Nasdaq World Headquarters in New York City, on May 19, 2026.

The live event and a replay of the presentation can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.

About Lexicon Pharmaceuticals   
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit www.lexpharma.com.  

For Media Inquiries:
Dave Belian
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com

For Investor Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Lexicon Pharmaceuticals (LXRX) present at the 4th Annual H.C. Wainwright BioConnect Investor Conference?

Lexicon Pharmaceuticals management will participate in a fireside chat on May 19, 2026. According to the company, the session is part of the 4th Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq World Headquarters in New York City.

Where is the H.C. Wainwright BioConnect Investor Conference featuring Lexicon Pharmaceuticals (LXRX) being held?

The conference featuring Lexicon Pharmaceuticals will take place at Nasdaq World Headquarters in New York City. According to the company, its management will join a fireside chat there on May 19, 2026.

How can investors watch Lexicon Pharmaceuticals’ (LXRX) fireside chat at the BioConnect Investor Conference?

Investors can access a live webcast and replay of Lexicon Pharmaceuticals’ fireside chat via the Events page of the company’s investor relations website, according to the company, offering convenient online access.

What type of presentation will Lexicon Pharmaceuticals (LXRX) give at the 2026 H.C. Wainwright BioConnect Conference?

Lexicon Pharmaceuticals management will participate in a fireside chat format at the conference. According to the company, this discussion will be available both live and as a replay through its investor relations Events page.

Is a replay available for Lexicon Pharmaceuticals’ (LXRX) 2026 H.C. Wainwright BioConnect Conference appearance?

Yes, a replay of Lexicon Pharmaceuticals’ fireside chat will be available. According to the company, both the live event and replay can be accessed from the Events section of its investor relations website.